Can We Outrun Cancer's Evolution? Why BrYet Is Targeting Cancer-Specific Phenotypes Read more →

AstraZeneca pens $1.7B kidney drug discovery pact with go-to Chinese partner CSPC Read more →

United Therapeutics pays $140M for thymic cell therapy startup Read more →